CNBC Halftime Report Final Trades: Freeport-McMoRan, Humana, Eli Lilly And Co
Portfolio Pulse from Benzinga Newsdesk
CNBC's Halftime Report discussed final trades involving Freeport-McMoRan (FCX), Humana (HUM), and Eli Lilly and Co (LLY).
November 06, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Freeport-McMoRan (FCX) was discussed in CNBC's Halftime Report final trades.
The news mentions FCX as part of the final trades discussed on CNBC's Halftime Report. This could potentially influence investor sentiment and trading behavior, but the exact impact is uncertain without more specific information.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEUTRAL IMPACT
Humana (HUM) was discussed in CNBC's Halftime Report final trades.
The news mentions HUM as part of the final trades discussed on CNBC's Halftime Report. This could potentially influence investor sentiment and trading behavior, but the exact impact is uncertain without more specific information.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEUTRAL IMPACT
Eli Lilly and Co (LLY) was discussed in CNBC's Halftime Report final trades.
The news mentions LLY as part of the final trades discussed on CNBC's Halftime Report. This could potentially influence investor sentiment and trading behavior, but the exact impact is uncertain without more specific information.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100